V
Vincent T.H.B.M. Smit
Researcher at Leiden University Medical Center
Publications - 163
Citations - 11210
Vincent T.H.B.M. Smit is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: Breast cancer & Endometrial cancer. The author has an hindex of 50, co-authored 147 publications receiving 8598 citations. Previous affiliations of Vincent T.H.B.M. Smit include Loyola University Medical Center & The Breast Cancer Research Foundation.
Papers
More filters
Journal ArticleDOI
Intraplacental choriocarcinoma as an unexpected cause of intrauterine death at term
TL;DR: In this article, a case of intraplacental choriocarcinoma was presented, in which the patient delivered a stillborn baby at term after a hydatidiform mole with persistence of throphoblastic disease.
Journal ArticleDOI
Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients
J.G.H. van Nes,Vincent T.H.B.M. Smit,Hein Putter,Peter J. K. Kuppen,Seung Jin Kim,M Daito,J Ding,Masaki Shibayama,Shigehiro Numada,Keigo Gohda,Tomoko Matsushima,Hideki Ishihara,Shinzaburo Noguchi,C.J.H. van de Velde +13 more
TL;DR: CDK- based risk is a prognostic marker of distance recurrence of patients with early breast cancer and more validation would be warranted to use of CDK-based risk into clinical practice.
Journal ArticleDOI
Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract.
Vincent T.H.B.M. Smit,Gert Jan Fleuren,J.C. van Houwelingen,S. T. Zegveld,N. Kuipers-Dijkshoorn,C.J. Cornelisse +5 more
TL;DR: Flow cytometric DNA‐ploidy analysis can be helpful in the identification of metastatic disease in patients with multiple female genital tract malignant tumors, supporting a metastatic process rather than the occurrence of multiple primary tumors in these patients.
Journal ArticleDOI
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer.
E.J. Blok,C.C. Engels,G. Dekker-Ensink,Elma Meershoek-Klein Kranenbarg,Hein Putter,Vincent T.H.B.M. Smit,Gerrit-Jan Liefers,James P Morden,Judith M Bliss,R. Charles Coombes,John M. S. Bartlett,Judith R. Kroep,Cornelis J.H. van de Velde,Peter J. K. Kuppen +13 more
TL;DR: This study is the first to propose the number of CD8-positive TILs as potential predictive markers for endocrine therapy, with the low presence ofCD8- positive Tils associated to benefit for exemestane-inclusive therapy.
Journal ArticleDOI
Total Number of Lymph Nodes in Oncologic Resections, Is There More to Be Found?
Kirsten J. de Burlet,Mari F.C.M. van den Hout,Hein Putter,Vincent T.H.B.M. Smit,Henk H. Hartgrink +4 more
TL;DR: Significantly more lymph nodes can be found in oncologic specimens when more time is invested in the search and this will result in more accurate staging of the tumor.